POM-V Prescription Required

Marbosyva 100 mg/ml Solution for Injection for Cattle and Pigs

Active ingredient: Marbofloxacin

Form

Injection

Species

Cattle Pigs

Manufacturer

Laboratorios SYVA S.A.

VMD MA No.

31592/5005

What it's used for

In cattle: - Treatment of respiratory infections caused by marbofloxacin-susceptible strains of Histophilus and bovis - Treatment of acute forms of mastiti...

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Marbofloxacin

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Marbosyva 100 mg/ml Solution for Injection for Cattle and Pigs — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 26 Mar 2026.

In cattle:
- Treatment of respiratory infections caused by marbofloxacin-susceptible strains of
Histophilus and
bovis
- Treatment of acute forms of mastitis induced by marbofloxacin-susceptible
Escherichia coli strains, during lactation.

Revised: May 2025
AN: 01306/2023
In pigs (sows):
- Treatment of Postpartum Dysgalactiae Syndrome, PDS (Metritis Mastitis Agalactia
Syndrome) caused by marbofloxacin-susceptible bacterial strains.

Do not use in cases where the pathogen involved is resistant to other
fluoroquinolones (cross resistance).
Do not use in cases of hypersensitivity to the active substance, to any other
quinolone or to any of the excipients.

Cattle and pigs:
Very rare
(<1 animal / 10,000 animals
treated, including isolated
reports):
Injection site lesion
1,2
Injection site reactions (such as pain and swelling)
1
Inflammatory lesions following subcutaneous administration
Following intramuscular administration, may persist for at least 12 days after
injection.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or its local representative or the national
competent authority via the national reporting system. See also the last section of the
package leaflet for respective contact details.

None.

Special precautions for use in animals
Official and local antimicrobial policies should be taken into account when the product
is used.
Fluoroquinolones should be reserved for the treatment of clinical conditions which
have responded poorly, or are expected to respond poorly, to other classes of
antimicrobials.
Whenever possible, fluoroquinolones should only be used based on susceptibility
testing.
Use of the product deviating from the instructions given in the SPC may increase the
prevalence of bacteria resistant to the fluoroquinolones and may decrease the
effectiveness of treatment with other quinolones due to the potential for cross
resistance.
The efficacy data showed that the product has insufficient efficacy for the treatment
of acute forms of mastitis induced by gram-positive bacteria.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
People with known hypersensitivity to (fluoro)quinolones should avoid contact with
the veterinary medicinal product.
Care should be taken to avoid accidental self injection, it can induce a slight irritation.
In case of accidental self injection, seek medical advice immediately and show the
package leaflet or the label to the physician.

Revised: May 2025
AN: 01306/2023
In case of contact with skin or eyes, rinse with plenty of water.
Wash hands after use.
Special precautions for the protection of the environment
Not applicable.
Other precautions
None.

None known.

Do not freeze.
Keep the vial in the outer carton in order to protect from light.

Revised: May 2025
AN: 01306/2023

Cattle:
IndicationRespiratoryMastitis
Dosage
2 mg/kg for 3 to 5
days (IV/IM/SC)
8 mg/kg on a single
occasion (IM)
2mg/kg for 3 days
(IV/IM/SC)
Meat and offal6 days3 days6 daysMilk36 hours72 hours36 hours
Pigs:
Meat and offal: 4 days
5.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.